We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

95 hedge funds and large institutions have $811M invested in Enfusion, Inc. in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,956% more call options, than puts

Call options by funds: $365K | Put options by funds: $9K

317% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 6

122% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 18

25% more funds holding

Funds holding: 7695 (+19)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

2% less capital invested

Capital invested by funds: $830M → $811M (-$19M)

Holders
95
Holders Change
+19
Holders Change %
+25%
% of All Funds
1.37%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
25
Increased
40
Reduced
18
Closed
6
Calls
$365K
Puts
$9K
Net Calls
+$356K
Net Calls Change
+$111K
Name Holding Trade Value Shares
Change
Change in
Stake
American Century Companies
51
American Century Companies
Missouri
$283K +$61.9K +7,038 +30%
ECM
52
ExodusPoint Capital Management
New York
$268K +$255K +28,926 New
LSPW
53
Lake Street Private Wealth
Illinois
$231K -$792 -90 -0.4%
CS
54
Credit Suisse
Switzerland
$218K +$18.1K +2,059 +10%
HF
55
HRT Financial
New York
$216K +$206K +23,459 New
MIM
56
MetLife Investment Management
New Jersey
$192K
AIG
57
American International Group
New York
$180K +$6.47K +735 +4%
BFG
58
Bleakley Financial Group
New Jersey
$176K +$168K +19,054 New
SW
59
Simplicity Wealth
New Jersey
$176K +$167K +18,999 New
JP Morgan Chase
60
JP Morgan Chase
New York
$170K -$58K -6,594 -26%
Deutsche Bank
61
Deutsche Bank
Germany
$145K -$3.26K -370 -2%
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$142K -$4.79K -545 -3%
Mirae Asset Global Investments
63
Mirae Asset Global Investments
South Korea
$140K
Wells Fargo
64
Wells Fargo
California
$128K +$18.9K +2,146 +18%
TI
65
Trexquant Investment
Connecticut
$124K +$117K +13,353 New
Susquehanna International Group
66
Susquehanna International Group
Pennsylvania
$123K -$98.3K -11,167 -46%
SFI
67
Susquehanna Fundamental Investments
Pennsylvania
$122K +$116K +13,214 New
VOYA Investment Management
68
VOYA Investment Management
Georgia
$118K -$24.7K -2,802 -18%
JF
69
Jump Financial
Illinois
$114K +$108K +12,300 New
Citigroup
70
Citigroup
New York
$110K +$28.9K +3,290 +38%
QC
71
Quadrature Capital
United Kingdom
$109K +$104K +11,826 New
QT
72
Quantbot Technologies
New York
$107K +$101K +11,521 New
T. Rowe Price Associates
73
T. Rowe Price Associates
Maryland
$102K +$96.9K +11,013 New
VI
74
Versor Investments
New York
$97.1K +$92.4K +10,500 New
Invesco
75
Invesco
Georgia
$97K +$3.16K +359 +4%

ENFN Hedge Fund Activity: Q1 2024 in Review

95 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q1 2024, worth a combined $811M — down 2.3% from $830M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ENFN positions and 6 closed out — a net gain of 19 holders — while 40 added to existing stakes and 18 trimmed.

The largest buyer was Lead Edge Capital Management, opening a new position worth an estimated $7.49M. The largest seller was Brown Capital Management, cutting an estimated $16.2M.

  • 95 institutional investors held Enfusion, Inc. (ENFN) as of Q1 2024, up from 76 in Q4 2023.
  • Funds reported $811M of Enfusion, Inc. stock for Q1 2024, down 2.3% quarter-over-quarter.
  • 25 funds opened new Enfusion, Inc. positions in Q1 2024 and 6 closed out, a net change of +19 holders.
  • The largest Enfusion, Inc. buyer in Q1 2024 was Lead Edge Capital Management, an estimated $7.49M added.
  • The largest Enfusion, Inc. seller in Q1 2024 was Brown Capital Management, an estimated $16.2M sold.

Based on aggregated 13F filings for Q1 2024.